Tuesday, November 10, 2026
Home Authors Posts by Ogkologos

Ogkologos

4396 POSTS 0 COMMENTS

ESMO Launches Clinical Trials Funding Initiative to Optimise Cancer Care Pathways

Ogkologos -
0

Daraxonrasib Shows Antitumour Activity in Patients with Previously Treated Metastatic RAS-mutated...

Ogkologos -
0

FDA Approves Gedatolisib with Fulvestrant, With or Without Palbociclib, for HR-positive,...

Ogkologos -
0

Potential Role of an Activated Tumour Immune Microenvironment in Predicting Benefit...

Ogkologos -
0

Perioperative Pembrolizumab Plus Neoadjuvant Chemotherapy Continues to Prolong EFS and OS...

Ogkologos -
0

Patient Guide in Soft Tissue Sarcoma Now Available Also in Ukrainian

Ogkologos -
0

ESMO Welcomes European Parliament (EP) report on Psychosocial Risks (PSR) at...

Ogkologos -
0

Adjuvant Pembrolizumab Continues to Demonstrate Benefit in DFS and OS Among...

Ogkologos -
0

FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic...

Ogkologos -
0

ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research,...

Ogkologos -
0
1...678...440Page 7 of 440

MOST POPULAR

Load more

HOT NEWS

Information on cancer, treatments, support and developments in oncology.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2026 Ogkologos.com